Bacteriostatic diluent in the other chamber
The findings showed that both the high-carbohydrate and high-protein meal significantly reduced peak BAC compared to fasting, with the high-protein condition producing the greater reduction
Practical take For clinicians, this reinforces a more nuanced approach: Match the drug to the patient profile Look beyond average weight loss alone Consider tolerability, adherence, comorbidities, access, and long-term strategy The obesity pipeline is getting deeperand that is good news for patients
You know, there was no risk of infection or anything like that, even though he was a just a few weeks from his shoulder surgery
Available from: 10 Ter Meulen BC, Maas ET, Vyas A, et al
However, the FDA has not approved it for human use